DSM-Firmenich AG (ENXTAM:DSFIR) (the Company or dsm-firmenich) and Koninklijke DSM N.V. (DSM B.V.) (DSM) announced that the remaining holders of DSM ordinary shares will have the opportunity to sell their DSM ordinary shares to dsm-firmenich through the voluntary tender offer launched by dsm-firmenich January 8, 2024. The details of the tender offer are set out in this press release. Statutory Buy-Out: dsm-firmenich started a statutory buy-out procedure (the Buy-Out) on July 17, 2023 to acquire the remaining ordinary shares, about 3.9%, in DSM, previously Koninklijke DSM N.V. (the Shares).

On such date, dsm-firmenich already held 96.1% of the Shares. For this Buy-Out, the Company has requested the Enterprise Chamber of the Amsterdam Court of Appeal (Ondernemingskamer) to set ? in line with past practice ?

the fair price of the Shares at the closing share price of a dsm-firmenich ordinary share on Euronext Amsterdam on May 3, 2023. This price amounts to ?116, minus the dividend paid on the Shares of ?22.58 on July 3, 2023, and with any further dividends or other distributions yet to be paid on the Shares also to be deducted. This Buy-Out may extend well into 2024.